US Patent 7989594 Modified antibody fab fragments
Patent 7989594 was granted and assigned to Celltech R&D Limited on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+336 characters)
Article
Patent abstract
The present invention provides antibody Fab fragments in which the heavy chain constant region terminates at the interchain cysteine of CH1. Also provided are antibody Fab fragments in which the heavy chain constant region terminates at the interchain cysteine of CH1 to which one or more effector molecules are attached.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07989594 Modified antibody fab fragments US Patent 7989594 Modified antibody fab fragments
Infobox
Patent Number
0798959400
Patent Number
798959400
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079895940
Date of Patent
August 2, 2011
0Patent Application Number
105627460
Date Filed
July 1, 2004
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079895940
Date of Patent
August 2, 2011
0Patent Application Number
105627460
Date Filed
July 1, 2004
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07989594 Modified antibody fab fragments
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07989594
Date of patent
August 2, 2011
Patent application number
10562746
Date Filed
July 1, 2004
Patent primary examiner
Find more entities like US Patent 7989594 Modified antibody fab fragments
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.